An unclear return on investment is one of the biggest challenges facing pharma’s digital initiatives. We work with our partners to identify the most important and relevant KPIs and use the data generated by MyTherapy to provide reports that clearly define the commercial success of digital tools and services.
MyTherapy data can provide insights into where your product is (and is not) being prescribed, in real-time. This data helps pharma make informed decisions regarding the use of resources to help maximize salesforce effectiveness.
Launching a new product? We use real-world data from MyTherapy users taking medications with comparable characteristics to create DigiSimilars, complimenting typical market research activities to help pharma predict patients’ behavior once the product hits the market.
Once new products hit the market, data from MyTherapy can be used to generate actionable insights, helping pharma navigate the crucial early stages of a product's lifecycle and make informed decisions.
